2009
DOI: 10.1086/644510
|View full text |Cite
|
Sign up to set email alerts
|

Evidence for the Transmission ofPlasmodium vivaxin the Republic of the Congo, West Central Africa

Abstract: Plasmodium vivax is not thought to be transmitted in western and central Africa, because of the very high prevalence of the red blood cell Duffy-negative phenotype in local populations, a condition which is thought to confer complete resistance against blood infection with P. vivax. There are, however, persistent reports of travelers returning from this region with P. vivax infections. To investigate whether transmission occurs in this region, the presence of antibodies specific to P. vivax preerythrocytic-sta… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

6
66
1
1

Year Published

2010
2010
2022
2022

Publication Types

Select...
7
2
1

Relationship

1
9

Authors

Journals

citations
Cited by 77 publications
(74 citation statements)
references
References 18 publications
6
66
1
1
Order By: Relevance
“…Similar infections have been reported in Brazil [26] and Kenya [23]. Additional cases of infection in Duffy antigen negative individuals have been reported from the Congo [27] and Uganda [28]. A study in Brazil of the protection against P. vivax offered by the lack of the Duffy antigen found no differential resistance to P. vivax between Duffy antigen positive and negative individuals [2].…”
Section: Discussionsupporting
confidence: 58%
“…Similar infections have been reported in Brazil [26] and Kenya [23]. Additional cases of infection in Duffy antigen negative individuals have been reported from the Congo [27] and Uganda [28]. A study in Brazil of the protection against P. vivax offered by the lack of the Duffy antigen found no differential resistance to P. vivax between Duffy antigen positive and negative individuals [2].…”
Section: Discussionsupporting
confidence: 58%
“…P. vivax is extremely rare in humans in west and central Africa due to the near fixation of the Duffy-negative phenotype, which confers resistance to this parasite (21). Nonetheless, P. vivax seems to be able to cause clinical infection of Duffy-negative individuals in Madagascar (35) and P. vivax-specific antibodies have been reported in 13% of humans living in Pointe-Noire, a city in the Republic of Congo (36). To examine whether P. vivax is maintained in west central African human populations, we screened nearly 700 blood samples from Cameroonian villagers for P. vivax mitochondrial sequences (SI Appendix, Fig.…”
Section: Discussionmentioning
confidence: 99%
“…The presence of low levels of P. vivax infection is consistent with other observations of P. vivax infections in predominantly Duffynegative populations in East Africa. [22][23][24] Malaria prevalence in pregnant women at delivery dropped dramatically from 37% and 41% PCR positivity to Pf in 1996-1997 and 2000-200, respectively, to 1% in 2009-2010. This decrease corresponded to increased usage of bed nets and expanded use of malaria chemoprophylaxis during pregnancy in the population (Table 3) and throughout the Coast Province of Kenya, where 34% and 10% of households had any bed nets and long-lasting insecticidal nets (LLINs), respectively, in 2003 compared with a boost in bed net usage in 2008-2009 to 71% and 66%, respectively.…”
Section: Discussionmentioning
confidence: 99%